Key result
Review evaluates cardiac biomarkers for clinical utility in assessing perioperative myocardial injury during noncardiac surgery.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Biomarker assessment of perioperative injury warrants caution in noncardiac surgery; level 5 evidence leaves clinical utility open.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Foëx et al. (2022) studied this question. Cardiac biomarkers are evaluated for their clinical utility in assessing perioperative myocardial injury among patients undergoing noncardiac surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: